| Metric | Current Period | Same Period of Previous Year | YoY |
|---|---|---|---|
| Revenue | ¥843.5B | ¥832.5B | +1.3% |
| Operating Income | ¥99.5B | ¥82.2B | +21.1% |
| Ordinary Income | ¥121.3B | ¥62.8B | +93.2% |
| Net Income | ¥65.4B | ¥46.4B | +40.8% |
| ROE | 4.0% | 2.8% | - |
For Q2 (cumulative interim period) of the fiscal year ending December 2026, operating income increased by double digits due to revenue growth and improvements in the cost structure, confirming enhanced profitability. Revenue was ¥843.5B (¥832.5B in the same period of the previous year, YoY+1.3%), operating income was ¥99.5B (¥82.2B, YoY+21.1%), ordinary income was ¥121.3B (¥62.8B, YoY+93.2%), and net income attributable to owners of the parent was ¥65.4B (¥46.4B, YoY+40.8%). The operating margin improved by +1.9pt to 11.8% from 9.9% in the same period of the previous year, while the sharp increase in ordinary income was primarily attributable to the recognition of ¥19.6B in foreign exchange gains. Although extraordinary losses of ¥22.4B were recorded, including ¥20.8B in business structure reform costs, the earnings benefit from higher operating income exceeded these losses, resulting in higher revenue and earnings.
【Revenue】Revenue was ¥843.5B, representing a modest increase of +1.3% year on year. The BeautyCare Business, which accounts for 94.8% of the revenue mix, led overall performance with revenue of ¥814.1B (+1.4%). The RealEstate Business generated ¥18.0B (+4.1%), while other businesses, including building maintenance, generated ¥26.2B (+5.6%); all secured positive growth. The high concentration of revenue in a single business, BeautyCare, remains unchanged, and demand trends in this business continue to determine overall company performance.
【Profit and Loss】Operating income was ¥99.5B (YoY+21.1%), and the operating margin improved by +1.9pt to 11.8% from 9.9% in the previous year. The gross margin declined by -0.5pt to 81.2% from 81.7% in the previous year; however, the SG&A ratio improved by -2.4pt to 69.4% from 71.9%, with cost efficiencies offsetting the deterioration in the gross margin. Ordinary income of ¥121.3B (YoY+93.2%) increased substantially more than operating income (+21.1%), mainly due to the significant contribution of ¥19.6B in foreign exchange gains recorded in non-operating income. Although profit before taxes was limited to ¥98.9B following the recognition of ¥22.4B in extraordinary losses, primarily ¥20.8B in business structure reform costs, net income remained at a high growth rate of ¥65.4B (YoY+40.8%) even after ordinary income and extraordinary losses. In conclusion, revenue and earnings increased.
The BeautyCare Business generated revenue of ¥814.1B (+1.4%) and operating income of ¥99.5B (+23.4%), with a margin of 12.2% (improved year on year), leading the improvement in company-wide earnings through profit growth exceeding revenue growth. The RealEstate Business generated revenue of ¥18.0B (+4.1%) and operating income of ¥4.2B (-1.4%), representing a slight decline in earnings; however, it maintained a highly profitable structure, with a margin of 23.6%, substantially above those of the other segments. Other businesses, including building maintenance, posted revenue of ¥26.2B (+5.6%) and operating income of ¥1.0B (+47.1%), showing high growth rates, although their earnings contribution remained limited, with a margin of 3.9%. After deducting adjustments for company-wide expenses and other items of -¥5.2B from total segment profit, consolidated operating income reached ¥99.5B. Improvement in BeautyCare’s profitability was therefore the substantive driver of consolidated performance.
【Profitability】The operating margin improved to 11.8% (9.9% in the same period of the previous year, +1.9pt), while the net margin improved to 7.8% (5.6%, +2.2pt), indicating a continuing improvement trend. ROE was 4.0%. Based on a decomposition into a net margin of 7.8%, total asset turnover of 0.43x (revenue of ¥843.5B ÷ average total assets of ¥1975.4B), and financial leverage of 1.22x, the improvement in profitability was the primary factor, while the contribution from leverage was minimal.【Cash Quality】Although the cash flow statement has not been disclosed, the balance sheet shows that cash and deposits declined by -16.5% year on year to ¥498.9B, while current securities increased by 121.6% to ¥109.6B (+121.6%) and investment securities increased by 43.0% to ¥209.4B (+43.0%), indicating a shift of funds from cash to securities.【Investment Efficiency】Total asset turnover of 0.43x remains subdued due to the substantial balances of inventory and investment securities.【Financial Soundness】The equity ratio remained high at 82.1% (82.3% in the previous year). Since interest-bearing debt is effectively close to zero, the scope for improving capital efficiency through financial leverage is limited, but financial safety is extremely high.
As cash flow statement data has not been disclosed, fund movements are analyzed based on changes in the balance sheet. While cash and deposits declined by -16.5% year on year to ¥498.9B, current securities increased to ¥109.6B (+121.6%) and investment securities increased to ¥209.4B (+43.0%), suggesting that a portion of funds shifted from cash holdings to securities investments. Accounts receivable and notes receivable declined to ¥165.8B (-5.9%), indicating progress in receivables collection. Meanwhile, inventories increased to ¥126.8B (+4.1%), and accounts payable and notes payable expanded to ¥30.0B (+36.1%), suggesting higher activity levels in both procurement and inventory. As interest-bearing debt is virtually nonexistent, funds generated from operating activities are considered to be primarily allocated to securities investments, dividend payments, and other shareholder returns.
The core of recurring earnings power in the current period was operating income of ¥99.5B from the BeautyCare Business, and the increase in operating income (+21.1%) can be viewed as a high-quality improvement accompanied by cost optimization. On the other hand, the sharp increase in ordinary income (+93.2%) depended significantly on the non-operating, non-recurring factor of ¥19.6B in foreign exchange gains. Although non-operating income represented only 2.8% of revenue, it was equivalent to approximately two-tenths of operating income; therefore, when evaluating the level of ordinary income, it is necessary to distinguish it from underlying earnings excluding foreign exchange factors. Extraordinary losses of ¥22.4B, including ¥20.8B in business structure reform costs, were one-time expenses that weighed on net income but may contribute to improvements in the SG&A ratio from the next fiscal year onward. Comprehensive income was ¥55.6B, below net income of ¥65.4B. The primary cause of the difference was foreign currency translation adjustments of -¥13.1B, with translation losses on overseas assets and foreign subsidiaries creating the divergence from net income.
The full-year company plan calls for revenue of ¥1730.0B (YoY+1.6%), operating income of ¥173.0B (YoY+10.2%), ordinary income of ¥173.0B (YoY+1.6%), and net income attributable to owners of the parent of ¥90.0B. As of the interim period, progress rates were 48.8% for revenue, 57.5% for operating income, 70.2% for ordinary income, and 72.7% for net income, exceeding the standard progress rate of 50% at each level from operating income downward. In particular, the high progress rates for ordinary income and net income reflect the boost from the non-recurring factor of ¥19.6B in foreign exchange gains during the first half. If this foreign exchange effect reverses or normalizes in the second half, the pace of progress may slow. There were no revisions to the earnings forecast or dividend forecast during the quarter, and management has maintained its initial plans.
The interim dividend was ¥21 per share, unchanged from ¥21 in the same period of the previous year. The payout ratio based on interim net income was 71.1%, calculated as DPS of ¥21 divided by EPS of ¥29.55. Under the full-year company plan, the payout ratio is 127.9%, calculated based on a dividend of ¥52 and forecast EPS of ¥40.67, representing shareholder returns exceeding the planned earnings level. There has been no revision to the dividend forecast, and no disclosure regarding share repurchases; accordingly, shareholder returns are evaluated solely using the payout ratio. Given the high level of financial soundness, with an equity ratio of 82.1% and virtually no interest-bearing debt, short-term payment capacity is sufficient. However, because the planned payout ratio exceeds the earnings level, the sustainability of earnings growth will determine the stability of future shareholder returns.
Business concentration risk: The BeautyCare Business accounts for 94.8% of revenue, creating a structure in which fluctuations in demand for this business directly affect overall consolidated performance. The RealEstate Business and other businesses together account for only 5.2% of revenue, limiting the diversification benefit.
Earnings volatility from foreign exchange fluctuations: Foreign exchange gains of ¥19.6B account for a significant portion of the +¥58.5B increase in ordinary income, indicating high foreign exchange sensitivity in non-operating income and expenses. If exchange rates reverse, the boost to ordinary income may dissipate.
Market price fluctuation risk of investment securities: Investment securities increased by +43.0% year on year to ¥209.4B, and their proportion of total assets has also risen. During periods of declining market prices, net assets and comprehensive income may be affected through valuation differences on available-for-sale securities.
| Metric | Company | Median (IQR) | Delta |
|---|---|---|---|
| Operating Margin | 11.8% | 9.7% (5.4%–23.7%) | +2.1pt |
| Net Margin | 7.8% | 5.4% (1.3%–20.1%) | +2.3pt |
| In terms of profitability, both the operating margin and net margin exceed the industry medians, placing the company at a relatively high level within the industry. |
| Metric | Company | Median (IQR) | Delta |
|---|---|---|---|
| Revenue Growth Rate (YoY) | 1.3% | 10.6% (-3.4%–25.4%) | -9.3pt |
| In terms of growth, the revenue growth rate is substantially below the industry median, placing the company in the low-growth group within the industry. |
※Source: Compiled by the Company
The improvement in the SG&A ratio by -2.4pt year on year and the increase in the operating margin to 11.8% indicate progress in structural cost efficiencies that absorbed the -0.5pt decline in the gross margin. This is an important point when assessing the sustainability of the improvement in profitability.
The substantial increase in ordinary income (+93.2%) is highly dependent on the non-recurring factor of ¥19.6B in foreign exchange gains. When evaluating normalized earnings power, it is appropriate to use operating income (+21.1%) as the benchmark.
The progress rate against the full-year plan is high at 72.7% for net income; however, it is necessary to monitor changes in the pace of progress if the foreign exchange effect from the first half normalizes or reverses in the second half.
This is a reference range mechanically calculated solely from publicly disclosed data using a residual income model (Ohlson-type model with an explicit 5-year fade). It is not a forecast of the market share price or a recommendation of any specific investment action.
| Scenario | Theoretical Share Price |
|---|---|
| bear | ¥657 |
| base | ¥670 |
| bull | ¥675 |
| Calculation Assumption | Value |
|---|---|
| Book Value per Share (BPS) | ¥730 |
| Adjusted Forecast EPS | ¥44.7 |
| Cost of Equity r | 9.27% (10-year Japanese government bond 2.77% + equity risk premium 6.00% + size premium 0.50%) |
| Residual Income Persistence Factor ω / Explicit Forecast Period | 0.62 / 5 years |
| Assumed Payout Ratio | 100.0% |
| Forecast EPS Confidence Adjustment | ×1.100 (based on leading progress against the full-year forecast) |
| Implied PBR / PER |
Sensitivity: ¥652–¥688 at ±1% for the cost of equity, and ¥668–¥671 at ±0.1 for ω.
Notes:
(Calculation model: Residual Income Model / Interest Rate Reference Month: 2026-07 / This value does not predict or guarantee future share prices)
This report is an earnings analysis document automatically generated by AI based on XBRL earnings release data. It does not recommend investment in any specific security. The industry benchmarks are reference information compiled by the Company based on publicly disclosed earnings data. Investment decisions should be made at your own responsibility, after consulting a professional as necessary.
---End of Report---
| 0.92x / 15.0x |
These are mechanically computed values based on a residual income model. They are not a forecast of market prices or a recommendation of any investment action, and do not predict or guarantee future share prices. Historical values are computed retrospectively using current guidance-achievement statistics.